Sebastien P, Tabruyn
Sebastien P, Tabruyn
TransCure bioServices
Verified email at tcbioservices.com - Homepage
Title
Cited by
Cited by
Year
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
J Halkein, SP Tabruyn, M Ricke-Hoch, A Haghikia, M Scherr, ...
The Journal of clinical investigation 123 (5), 2143-2154, 2013
4212013
Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors
B Sennino, T Ishiguro-Oonuma, Y Wei, RM Naylor, CW Williamson, ...
Cancer discovery 2 (3), 270-287, 2012
4022012
miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization
K Valencia, D Luis-Ravelo, N Bovy, I Antón, S Martínez-Canarias, ...
Molecular oncology 8 (3), 689-703, 2014
1462014
Molecular pathways of angiogenesis inhibition
SP Tabruyn, AW Griffioen
Biochemical and biophysical research communications 355 (1), 1-5, 2007
1442007
GATA2 is required for lymphatic vessel valve development and maintenance
J Kazenwadel, KL Betterman, CE Chong, PH Stokes, YK Lee, GA Secker, ...
The Journal of clinical investigation 125 (8), 2979-2994, 2015
1432015
Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer
N Bovy, B Blomme, P Frères, S Dederen, O Nivelles, M Lion, O Carnet, ...
Oncotarget 6 (12), 10253, 2015
1242015
Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways
C Verhaeghe, C Remouchamps, B Hennuy, A Vanderplasschen, ...
Biochemical pharmacology 73 (12), 1982-1994, 2007
1132007
Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance
D Piwnica, P Touraine, I Struman, S Tabruyn, G Bolbach, C Clapp, ...
Molecular endocrinology 18 (10), 2522-2542, 2004
1052004
NF-κB: a new player in angiostatic therapy
SP Tabruyn, AW Griffioen
Angiogenesis 11 (1), 101-106, 2008
1042008
The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-κB
SP Tabruyn, CM Sorlet, F Rentier-Delrue, V Bours, RI Weiner, JA Martial, ...
Molecular Endocrinology 17 (9), 1815-1823, 2003
972003
Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation
J Fuxe, S Tabruyn, K Colton, H Zaid, A Adams, P Baluk, E Lashnits, ...
The American journal of pathology 178 (6), 2897-2909, 2011
812011
Angiopoietin-2-driven vascular remodeling in airway inflammation
SP Tabruyn, K Colton, T Morisada, J Fuxe, SJ Wiegand, G Thurston, ...
The American journal of pathology 177 (6), 3233-3244, 2010
792010
PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin
K Bajou, S Herkenne, VL Thijssen, S D'amico, A Bouche, S Tabruyn, ...
Nature medicine 20 (7), 741-747, 2014
762014
A new role for NF-[kappa] B in angiogenesis inhibition
SP Tabruyn, AW Griffioen
Cell death and differentiation 14 (8), 1393, 2007
732007
Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitors
B Sennino, F Kuhnert, SP Tabruyn, MR Mancuso, DD Hu-Lowe, CJ Kuo, ...
Cancer research 69 (10), 4527-4536, 2009
652009
Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-κB inhibition and gene expression signature
S Olivier, P Close, E Castermans, L De Leval, S Tabruyn, A Chariot, ...
Molecular pharmacology 69 (5), 1615-1623, 2006
612006
The Antiangiogenic Factor, 16-kDa Human Prolactin, Induces Endothelial Cell Cycle Arrest by Acting at Both the G0–G1 and the G2–M Phases
SP Tabruyn, NQN Nguyen, AM Cornet, JA Martial, I Struman
Molecular Endocrinology 19 (7), 1932-1942, 2005
602005
Angiostatic activity of the antitumor cytokine interleukin-21
K Castermans, SP Tabruyn, R Zeng, JR Van Beijnum, C Eppolito, ...
Blood, The Journal of the American Society of Hematology 112 (13), 4940-4947, 2008
592008
NF-κB activation in endothelial cells is critical for the activity of angiostatic agents
SP Tabruyn, S Mémet, P Avé, C Verhaeghe, KH Mayo, I Struman, ...
Molecular cancer therapeutics 8 (9), 2645-2654, 2009
442009
The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-κB activation
SP Tabruyn, C Sabatel, NQN Nguyen, C Verhaeghe, K Castermans, ...
Molecular endocrinology 21 (6), 1422-1429, 2007
432007
The system can't perform the operation now. Try again later.
Articles 1–20